Medicine manufacturer Cipla said on Tuesday it is rising up the production of antiviral drug remdesivir, used in COVID-19 treatment, by manufacturing the drug at its Goa plant. “Presently the requirement is enormous for remdesivir, also we’re scaling up our internal production of Remdesivir,” Kedar Upadhye, global chief financial officer of Cipla, told Moneycontrol. Upadhye…